• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多菌株益生菌通过调节微生物群衍生代谢物和血清素途径缓解腹泻。

Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway.

作者信息

Jeong Jin-Ju, Jin Yoo-Jeong, Ganesan Raja, Park Hee Jin, Min Byeong Hyun, Jeong Min Kyo, Yoon Sang Jun, Choi Mi Ran, Sharma Satya Priya, Jang You Jin, Min Uigi, Lim Jong-Hyun, Na Kyeong Min, Choi Jieun, Han Sang Hak, Ham Young Lim, Lee Do Yup, Kim Byung-Yong, Suk Ki Tae

机构信息

Institute for Liver and Digestive Disease, College of Medicine, Hallym University, Chuncheon, Korea.

R&D Center, Chong Kun Dang Healthcare, Seoul, Republic of Korea.

出版信息

Probiotics Antimicrob Proteins. 2024 Mar 12. doi: 10.1007/s12602-024-10232-4.

DOI:10.1007/s12602-024-10232-4
PMID:38467925
Abstract

Diarrhea, a common gastrointestinal symptom in health problems, is highly associated with gut dysbiosis. The purpose of this study is to demonstrate the effect of multistrain probiotics (Sensi-Biome) on diarrhea from the perspective of the microbiome-neuron axis. Sensi-Biome (Lactiplantibacillus plantarum, Bifidobacterium animalis subsp. lactis, Lactobacillus acidophilus, Streptococcus thermophilus, Bifidobacterium bifidum, and Lactococcus lactis) was administered in a 4% acetic acid-induced diarrhea rat model at concentrations of 1 × 10 (G1), 1 × 10 (G2), and 1 × 10 CFU/0.5 mL (G3). Diarrhea-related parameters, inflammation-related cytokines, and stool microbiota analysis by 16S rRNA were evaluated. A targeted and untargeted metabolomics approach was used to analyze the cecum samples using liquid chromatography and orbitrap mass spectrometry. The stool moisture content (p < 0.001), intestinal movement rate (p < 0.05), and pH (p < 0.05) were significantly recovered in G3. Serotonin levels were decreased in the multistrain probiotics groups. The inflammatory cytokines, serotonin, and tryptophan hydroxylase expression were improved in the Sensi-Biome groups. At the phylum level, Sensi-Biome showed the highest relative abundance of Firmicutes. Short-chain fatty acids including butyrate, iso-butyrate, propionate, and iso-valeric acid were significantly modified in the Sensi-Biome groups. Equol and oleamide were significantly improved in the multistrain probiotics groups. In conclusion, Sensi-Biome effectively controls diarrhea by modulating metabolites and the serotonin pathway.

摘要

腹泻是健康问题中常见的胃肠道症状,与肠道菌群失调高度相关。本研究的目的是从微生物群-神经元轴的角度证明多菌株益生菌(Sensi-Biome)对腹泻的影响。在4%乙酸诱导的腹泻大鼠模型中,以1×10(G1)、1×10(G2)和1×10 CFU/0.5 mL(G3)的浓度给予Sensi-Biome(植物乳杆菌、动物双歧杆菌亚种乳酸亚种、嗜酸乳杆菌、嗜热链球菌、两歧双歧杆菌和乳酸乳球菌)。评估了腹泻相关参数、炎症相关细胞因子以及通过16S rRNA进行的粪便微生物群分析。采用靶向和非靶向代谢组学方法,使用液相色谱和轨道阱质谱对盲肠样本进行分析。G3组的粪便水分含量(p<0.001)、肠道蠕动率(p<0.05)和pH值(p<0.05)显著恢复。多菌株益生菌组的血清素水平降低。Sensi-Biome组的炎症细胞因子、血清素和色氨酸羟化酶表达得到改善。在门水平上,Sensi-Biome显示厚壁菌门的相对丰度最高。Sensi-Biome组中包括丁酸、异丁酸、丙酸和异戊酸在内的短链脂肪酸发生了显著变化。多菌株益生菌组的雌马酚和油酰胺显著改善。总之,Sensi-Biome通过调节代谢物和血清素途径有效控制腹泻。

相似文献

1
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway.多菌株益生菌通过调节微生物群衍生代谢物和血清素途径缓解腹泻。
Probiotics Antimicrob Proteins. 2024 Mar 12. doi: 10.1007/s12602-024-10232-4.
2
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats.多菌株益生菌通过调节大鼠的微生物群、血清素和短链脂肪酸来缓解洛哌丁胺引起的便秘。
Front Microbiol. 2023 Jun 2;14:1174968. doi: 10.3389/fmicb.2023.1174968. eCollection 2023.
3
In Vitro Evaluation of Probiotic Properties of Two Novel Probiotic Mixtures, Consti-Biome and Sensi-Biome.两种新型益生菌混合物(康体宝和敏感宝)的益生菌特性的体外评估。
J Microbiol Biotechnol. 2023 Sep 28;33(9):1149-1161. doi: 10.4014/jmb.2303.03011. Epub 2023 Jun 19.
4
Complex probiotics alleviate ampicillin-induced antibiotic-associated diarrhea in mice.复合益生菌可减轻氨苄西林诱导的小鼠抗生素相关性腹泻。
Front Microbiol. 2023 Apr 14;14:1156058. doi: 10.3389/fmicb.2023.1156058. eCollection 2023.
5
Personalized probiotic strategy considering bowel habits: impacts on gut microbiota composition and alleviation of gastrointestinal symptoms via Consti-Biome and Sensi-Biome.考虑肠道习惯的个性化益生菌策略:通过Consti-Biome和Sensi-Biome对肠道微生物群组成的影响及胃肠道症状的缓解
Front Nutr. 2024 Feb 16;11:1302093. doi: 10.3389/fnut.2024.1302093. eCollection 2024.
6
Probiotic Therapy with and subsp. Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis.使用嗜酸乳杆菌和干酪乳杆菌亚种进行益生菌治疗可限制肥胖和化学诱导性结肠炎大鼠的梗死面积。
Microorganisms. 2022 Nov 18;10(11):2293. doi: 10.3390/microorganisms10112293.
7
subsp. XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.亚种 XLTG11 通过缓解炎症、增强肠道屏障功能和调节肠道菌群来改善抗生素相关性腹泻。
Food Funct. 2022 Jun 6;13(11):6404-6418. doi: 10.1039/d1fo04305f.
8
Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp. BB-12 on Fecal Microbiota, Gut Transit Time, and Short-Chain Fatty Acids in Healthy Young Adults.双歧杆菌 BB-12 对健康年轻成年人粪便微生物群、肠道转运时间和短链脂肪酸的传递效果的基质效应。
mSphere. 2021 Aug 25;6(4):e0008421. doi: 10.1128/mSphere.00084-21. Epub 2021 Jul 7.
9
Restitution of gut microbiota in Ugandan children administered with probiotics ( GG and subsp. BB-12) during treatment for severe acute malnutrition.在乌干达患有严重急性营养不良的儿童治疗期间给予益生菌(GG和BB-12亚种)后肠道微生物群的恢复情况。
Gut Microbes. 2020 Jul 3;11(4):855-867. doi: 10.1080/19490976.2020.1712982. Epub 2020 Jan 20.
10
Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients.术后益生菌给药可减轻结直肠癌患者化疗引起的胃肠道并发症和肠道微生物失调。
Nutrients. 2023 Jan 11;15(2):356. doi: 10.3390/nu15020356.

引用本文的文献

1
Impact of Probiotic Formula (Lacto-5X) on Constipation: Improvements in Gastrointestinal Symptoms, Gut Microbiome, and Metabolites.益生菌配方(Lacto-5X)对便秘的影响:改善胃肠道症状、肠道微生物群和代谢产物。
J Microbiol Biotechnol. 2025 Apr 9;35:e2412056. doi: 10.4014/jmb.2412.12056.
2
Enhancing Gut Microbiome and Metabolic Health in Mice Through Administration of Presumptive Probiotic Strain PE11.通过施用推定益生菌菌株PE11改善小鼠肠道微生物群和代谢健康
Nutrients. 2025 Jan 25;17(3):442. doi: 10.3390/nu17030442.
3
Probiotics alleviate painful diabetic neuropathy by modulating the microbiota-gut-nerve axis in rats.

本文引用的文献

1
Loose ends in the differential diagnosis of IBS-like symptoms.肠易激综合征样症状鉴别诊断中的未决问题。
Front Med (Lausanne). 2023 Jul 6;10:1141035. doi: 10.3389/fmed.2023.1141035. eCollection 2023.
2
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats.多菌株益生菌通过调节大鼠的微生物群、血清素和短链脂肪酸来缓解洛哌丁胺引起的便秘。
Front Microbiol. 2023 Jun 2;14:1174968. doi: 10.3389/fmicb.2023.1174968. eCollection 2023.
3
-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
益生菌通过调节大鼠肠道微生物群-肠道-神经轴来缓解疼痛性糖尿病神经病变。
J Neuroinflammation. 2025 Feb 2;22(1):30. doi: 10.1186/s12974-025-03352-3.
4
Effect of Dietary Sugarcane Bagasse on Reproductive Performance, Constipation, and Gut Microbiota of Gestational Sows.日粮甘蔗渣对妊娠母猪繁殖性能、便秘及肠道微生物群的影响
Animals (Basel). 2024 Aug 30;14(17):2523. doi: 10.3390/ani14172523.
源自短链脂肪酸和吲哚化合物通过调节肠-肝轴减轻非酒精性脂肪性肝病。
Front Microbiol. 2023 Mar 1;14:1129904. doi: 10.3389/fmicb.2023.1129904. eCollection 2023.
4
Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin.胆囊切除术后肠道微生物群的改变通过胆汁酸刺激结肠 5-羟色胺导致胆囊切除术后腹泻。
Gut Microbes. 2023 Jan-Dec;15(1):2168101. doi: 10.1080/19490976.2023.2168101.
5
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study.通过网络药理学研究阐明从肠道微生物群到缓解肥胖的益生元、益生菌、后生元和靶标。
Cells. 2022 Sep 16;11(18):2903. doi: 10.3390/cells11182903.
6
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease.乳杆菌和戊糖片球菌驱动的肠道微生物组和代谢组重编程可改善非酒精性脂肪性肝病的进展。
Clin Transl Med. 2021 Dec;11(12):e634. doi: 10.1002/ctm2.634.
7
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis.嗜酸乳杆菌通过降低胆固醇和脂肪变性来减轻非酒精性脂肪性肝病的进展。
Clin Mol Hepatol. 2021 Jan;27(1):110-124. doi: 10.3350/cmh.2020.0125. Epub 2020 Dec 3.
8
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.肠道微生物组和饮食在非酒精性脂肪性肝病发病机制中的作用。
Clin Mol Hepatol. 2021 Jan;27(1):22-43. doi: 10.3350/cmh.2020.0129. Epub 2020 Dec 10.
9
Health and disease markers correlate with gut microbiome composition across thousands of people.健康和疾病标志物与数千人的肠道微生物组组成相关。
Nat Commun. 2020 Oct 15;11(1):5206. doi: 10.1038/s41467-020-18871-1.
10
From intestinal dysbiosis to alcohol-associated liver disease.从肠道菌群失调到酒精相关性肝病。
Clin Mol Hepatol. 2020 Oct;26(4):595-605. doi: 10.3350/cmh.2020.0086. Epub 2020 Sep 11.